IL51934A - Indoleamine-n-methyltransferase inhibiting compositions comprising 3-substituted 2-imino-thiazoldines and thiazolines - Google Patents

Indoleamine-n-methyltransferase inhibiting compositions comprising 3-substituted 2-imino-thiazoldines and thiazolines

Info

Publication number
IL51934A
IL51934A IL51934A IL5193477A IL51934A IL 51934 A IL51934 A IL 51934A IL 51934 A IL51934 A IL 51934A IL 5193477 A IL5193477 A IL 5193477A IL 51934 A IL51934 A IL 51934A
Authority
IL
Israel
Prior art keywords
thiazoldines
thiazolines
indoleamine
imino
substituted
Prior art date
Application number
IL51934A
Other languages
English (en)
Other versions
IL51934A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL51934A0 publication Critical patent/IL51934A0/xx
Publication of IL51934A publication Critical patent/IL51934A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL51934A 1976-05-03 1977-04-25 Indoleamine-n-methyltransferase inhibiting compositions comprising 3-substituted 2-imino-thiazoldines and thiazolines IL51934A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/682,802 US4029803A (en) 1976-05-03 1976-05-03 Method of treatment with 2-iminothiazolidines and thiazolines

Publications (2)

Publication Number Publication Date
IL51934A0 IL51934A0 (en) 1977-06-30
IL51934A true IL51934A (en) 1980-01-31

Family

ID=24741190

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51934A IL51934A (en) 1976-05-03 1977-04-25 Indoleamine-n-methyltransferase inhibiting compositions comprising 3-substituted 2-imino-thiazoldines and thiazolines

Country Status (13)

Country Link
US (1) US4029803A (fr)
JP (1) JPS52133980A (fr)
AU (1) AU513234B2 (fr)
BE (1) BE854171A (fr)
DE (1) DE2719576A1 (fr)
FR (1) FR2350099A1 (fr)
GB (1) GB1526666A (fr)
IE (1) IE45040B1 (fr)
IL (1) IL51934A (fr)
NL (1) NL7704320A (fr)
NZ (1) NZ183929A (fr)
PH (1) PH13497A (fr)
ZA (1) ZA772615B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191408B (en) * 1984-04-25 1987-02-27 Egis Gyogyszergyar,Hu Process for preparing new imino-thiazolidine derivatives
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) * 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
HUE032891T2 (hu) 2012-12-17 2017-11-28 Parion Sciences Inc Klórpirazin-karboxamid-származékok nem kielégítõ nyálkahártya-hidratáció által elõsegített megbetegedések kezelésére
RU2671976C2 (ru) 2012-12-17 2018-11-08 Пэрион Сайенсиз, Инк. Соединения 3,5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Also Published As

Publication number Publication date
IE45040B1 (en) 1982-06-02
PH13497A (en) 1980-05-23
FR2350099A1 (fr) 1977-12-02
NZ183929A (en) 1981-10-19
BE854171A (fr) 1977-11-03
JPS52133980A (en) 1977-11-09
IE45040L (en) 1977-11-03
GB1526666A (en) 1978-09-27
AU513234B2 (en) 1980-11-20
US4029803A (en) 1977-06-14
IL51934A0 (en) 1977-06-30
NL7704320A (nl) 1977-11-07
FR2350099B1 (fr) 1979-03-02
ZA772615B (en) 1978-12-27
DE2719576A1 (de) 1977-11-24
AU2462977A (en) 1978-11-02

Similar Documents

Publication Publication Date Title
JPS5326331A (en) Decayeddtooth preventing composition
JPS5289649A (en) Compositions and process
JPS52112681A (en) Sensitive composition
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
JPS52100446A (en) Compositions and process
JPS52129791A (en) Sensitive composition
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
NZ184953A (en) 2-cyclopropylamino-4 6-diamino-s-triazines and insecticidal compositions
NZ183134A (en) I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
JPS53101539A (en) Anodyne and antiiinflamatory composition for local application
PH14589A (en) Dipepting derivatives and compositions containing same
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
JPS5289650A (en) Compositions and process
JPS5289648A (en) Compositions and process
IL51934A0 (en) Chemical compositions comprising 2-iminothiazolidines and thiazolines
NZ184808A (en) Heterocyclic compounds and pharmaceutical compositions
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
JPS52133954A (en) Compositions and process
IL52345A0 (en) Fungicidal and nematicidal compositions containing diphenyl-triazolyl-methanes
IL51365A (en) Coccidiocidal composition for poultriy comprising monensin and meticlorpindol
NZ183756A (en) Bis-penicillanoyloxy-alkanes and pharmaceutical compositions
JPS52100449A (en) Compositions and process
JPS5328587A (en) Clouddproofing and dewwproofing composition